Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis.
about
The Renin-Angiotensin-aldosterone system in vascular inflammation and remodelingDefects in cutaneous angiotensin-converting enzyme 2 and angiotensin-(1-7) production in postural tachycardia syndromeLong-term safety and efficacy of telmisartan/amlodipine single pill combination in the treatment of hypertensionAn evolving story of angiotensin-II-forming pathways in rodents and humansAutonomic, locomotor and cardiac abnormalities in a mouse model of muscular dystrophy: targeting the renin-angiotensin systemReview article: the pathophysiological roles of the renin-angiotensin system in the gastrointestinal tractThe role of the renin-angiotensin-aldosterone system in the pathobiology of pulmonary arterial hypertension (2013 Grover Conference series)Role of neurons and glia in the CNS actions of the renin-angiotensin system in cardiovascular controlPhysiology of kidney reninDifferential mechanisms of activation of the Ang peptide receptors AT1, AT2, and MAS: using in silico techniques to differentiate the three receptorsOcular Inserts for Sustained Release of the Angiotensin-Converting Enzyme 2 Activator, Diminazene Aceturate, to Treat Glaucoma in RatsGonadotropin stimulation increases the expression of angiotensin-(1--7) and MAS receptor in the rat ovaryAT2 receptors: beneficial counter-regulatory role in cardiovascular and renal functionAngiotensin II reduces membranous angiotensin-converting enzyme 2 in pressurized human aortic endothelial cells.Expression and activity profiles of DPP IV/CD26 and NEP/CD10 glycoproteins in the human renal cancer are tumor-type dependentACE2 activation promotes antithrombotic activity.The ACE2/Angiotensin-(1-7)/Mas Receptor Axis: Pleiotropic Roles in Cancer.Angiotensin-(1-7)-angiotensin-converting enzyme 2 attenuates reactive oxygen species formation to angiotensin II within the cell nucleus.Infusion of angiotensin-(1-7) reduces glomerulosclerosis through counteracting angiotensin II in experimental glomerulonephritisExercise training normalizes ACE and ACE2 in the brain of rabbits with pacing-induced heart failure.Deficiency of angiotensin-converting enzyme 2 causes deterioration of cognitive function.The renin angiotensin system and the metabolic syndromeRegulation of multiple renin-angiotensin system genes by Sry.Spectral imaging reveals microvessel physiology and function from anastomoses to thromboses.Reduced systolic pressure load decreases cell-cycle activity in the fetal sheep heart.Angiotensin-(1-7) reverses angiogenic dysfunction in corpus cavernosum by acting on the microvasculature and bone marrow-derived cells in diabetesNonclassical renin-angiotensin system and renal function.Nuclear angiotensin-(1-7) receptor is functionally coupled to the formation of nitric oxide.Developmental changes in AT1 and AT2 receptor-protein expression in ratsGlucocorticoid-induced fetal programming alters the functional complement of angiotensin receptor subtypes within the kidneyThe preventive effects of diminazene aceturate in renal ischemia/reperfusion injury in male and female rats.Stabilization of the angiotensin-(1-7) receptor Mas through interaction with PSD95.Beneficial effects of the activation of the angiotensin-(1-7) MAS receptor in a murine model of adriamycin-induced nephropathy.Renin-angiotensin system blockers protect pancreatic islets against diet-induced obesity and insulin resistance in miceStructural determinants for binding to angiotensin converting enzyme 2 (ACE2) and angiotensin receptors 1 and 2.Chronic oral administration of Ang-(1-7) improves skeletal muscle, autonomic and locomotor phenotypes in muscular dystrophy.ACE2 is augmented in dystrophic skeletal muscle and plays a role in decreasing associated fibrosis.Angiotensin (1-7) prevents angiotensin II-induced nociceptive behaviour via inhibition of p38 MAPK phosphorylation mediated through spinal Mas receptors in mice.Hemodynamic responses to angiotensin-(1-7) in women in their third trimester of pregnancy.Cardioprotective effects of telmisartan against heart failure in rats induced by experimental autoimmune myocarditis through the modulation of angiotensin-converting enzyme-2/angiotensin 1-7/mas receptor axis.
P2860
Q21284671-E9067504-1B0A-4333-BABA-701FD250BE3FQ24650489-41AFF8C8-4DA7-4AF2-8DEB-F525ACAF715BQ26824261-726FBFD1-4772-4EB3-85D9-FEE0DBFD4A8EQ26830036-03471A22-D4D4-4678-AC74-7877507FA28FQ26996208-EA5E3BDD-5D60-4D7D-8E72-30C28721130DQ27009109-F8E94BDD-1856-4624-BD6B-B854AEE01190Q27013946-E9F7B4F1-6E3C-4BE6-A1AE-D30B4CFD6C27Q28081615-9D9612EE-BBC0-4FD6-B21D-8A53343D8B29Q28279771-A48FCF0E-FD66-496A-A2B2-A29C17362093Q28533596-645185EB-517D-4B4F-B0DB-B3FE57C8534CQ28546739-C136C3FE-1D51-4A30-A1DE-9881C430313AQ28580709-953412D4-550E-4B80-A6B0-7F3D0F0D492CQ30415577-09500230-F2E8-406D-9E9F-B815D037E7DDQ33443452-B40A4A2F-E8A2-4BC5-80C5-9DBFB775374BQ33575499-B1B7B14F-6BBD-4DFA-BB81-5C92A56FB03DQ33611250-552F6FB7-D74F-430A-8F53-21464CEC854AQ33645806-EB94E114-B76A-47FF-B705-B9114F0435E0Q33652507-8D78AE2C-B079-444E-84BD-EFF4AB0F7F6CQ33727783-9A356B13-2087-442F-958A-C0E891842B5DQ33783409-FCA4CA9B-0CA5-446F-BBD8-73BEB738097BQ33914333-CAB72C47-D758-4F64-A54F-77D32E181FD2Q33915412-3A6BC870-96FD-41EF-AE27-3C2BA2FB3E72Q33962204-642B4082-DCB5-40FC-AA4F-0F90FECDB0CEQ34049847-CAB5E0D9-ACE9-4A06-B83B-5BB45D989E19Q34085575-6AECACDC-3303-4676-8789-5EBE7D9C48EFQ34111573-2AAB158D-C76E-42ED-8136-00F9B142E81CQ34293723-21422A98-F7D0-495A-A8D3-1EEA4BF9450AQ34305539-EAB80826-8E0D-424F-86B6-46F3725F1748Q34557839-D13EF950-4D0A-4409-BFBF-B33D904597F5Q34586584-6994B105-85AB-4ED5-8E34-5FDEAC4471CDQ34588469-BDD08CCF-B768-43EF-B504-EF624A9A7D32Q34735823-3C87516E-159D-4C53-BC84-CF9A90E8E176Q34770468-496D7376-FCC2-44BB-A58D-AC69AF7FC06EQ34872407-72AC9847-5903-4D61-ABF2-88B229F957B0Q35030794-5CCA1F15-3C04-497F-8369-12E7545CF328Q35053205-870ADCAD-C3E8-4B2F-BB73-8160C9574DE9Q35138448-A39D10BA-33EB-438E-AC2A-F1F69F5759A9Q35148155-025CCB3E-B2F4-43BD-92E7-F25EC414D6EDQ35171193-1D68F6E1-5899-4425-947C-31C40AA8244CQ35216408-FE530EAA-B0B5-44D8-8E4D-8370BF8E8280
P2860
Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Recent advances in the angiotensin-converting enzyme 2-angiotensin
@nl
Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis.
@en
type
label
Recent advances in the angiotensin-converting enzyme 2-angiotensin
@nl
Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis.
@en
prefLabel
Recent advances in the angiotensin-converting enzyme 2-angiotensin
@nl
Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis.
@en
P1476
Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis
@en
P2093
Anderson J Ferreira
P304
P356
10.1113/EXPPHYSIOL.2008.042002
P577
2008-02-29T00:00:00Z